Showing 4,601 - 4,620 results of 61,189 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((a decrease) OR (mean decrease)) ))', query time: 1.25s Refine Results
  1. 4601
  2. 4602

    DataSheet_1_Decreasing Shortest Path Length of the Sensorimotor Network Induces Frontal Glioma-Related Epilepsy.pdf by Shengyu Fang (9134117)

    Published 2022
    “…We believe that our findings indicate new directions of research that will contribute to future investigations of glioma-related epilepsy onset.…”
  3. 4603
  4. 4604
  5. 4605
  6. 4606
  7. 4607

    Data Sheet 1_Effect of threonine level in a high-protein diet on the growth performance and carcass characteristics of 50- to 91-day-old slow-growing indigenous male Boschveld chic... by Tebogo Mack Sekgotodi (22465483)

    Published 2025
    “…An experiment was conducted to determine the effect of dietary threonine level on the growth performance of slow-growing 50- to 91-day-old male Boschveld chickens. A total of 75 chickens were used in a complete randomized design comprising five dietary treatments, with three replicates and five chickens per replicate. …”
  8. 4608

    Table1_CLEC16A variants conferred a decreased risk to allergic rhinitis in the Chinese population.DOCX by Yongliang Niu (14245295)

    Published 2022
    “…This study investigated the association between CLEC16A variants and AR risk in the Chinese population.</p><p>Methods: We applied Agena MassARRAY technology platform to genotype five single nucleotide polymorphisms (SNPs) located in CLEC16A in 1004 controls and 995 cases. …”
  9. 4609

    Table1_CLEC16A variants conferred a decreased risk to allergic rhinitis in the Chinese population.DOCX by Yongliang Niu (14245295)

    Published 2022
    “…This study investigated the association between CLEC16A variants and AR risk in the Chinese population.</p><p>Methods: We applied Agena MassARRAY technology platform to genotype five single nucleotide polymorphisms (SNPs) located in CLEC16A in 1004 controls and 995 cases. …”
  10. 4610

    Time-dependent effects of increasing RSV concentrations on XBP1 splicing, CHOP expression and viability. by Cristina Rojas (667363)

    Published 2014
    “…The viability was evaluated using a MTT assay. The data are shown as the mean ± SD of three independent experiments. …”
  11. 4611
  12. 4612

    C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

    Published 2021
    “…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
  13. 4613

    C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

    Published 2021
    “…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
  14. 4614

    C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

    Published 2021
    “…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
  15. 4615

    C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

    Published 2021
    “…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
  16. 4616

    C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

    Published 2021
    “…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
  17. 4617
  18. 4618
  19. 4619

    ANOVA for DH (Y<sub>1</sub>) and IC<sub>50</sub> of LI (Y<sub>2</sub>). by Kittisak Kuptawach (18599047)

    Published 2024
    “…The peptide was synthesized and demonstrated LI with an IC<sub>50</sub> of 0.255 mM through a non-competitive mechanism, with a constant (K<sub>i</sub>) of 0.61 mM. …”
  20. 4620

    Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study by Shengnan Chen (3595319)

    Published 2022
    “…We found that DKD patients have a higher risk to develop 50% eGFR decline endpoint (HR:2.30, 95%CI [1.48–3.58], <i>p</i> < 0.001) and KRT endpoint (HR:1.64, 95%CI [1.13–2.37], <i>p</i> < 0.05) than NDKD patients. …”